Suven Life Sciences · NSE: SUVEN · BSE: 530239
Q3 FY19 results · Oct–Dec 2018
Suven Life Sciences reported revenue from operations of ₹129.02 crore and net profit of ₹25.23 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 129.02 | — | — | 89.52 | +44.1% |
| Other income | 5.76 | — | — | 6.59 | −12.5% |
| Total income | 134.78 | — | — | 96.11 | +40.2% |
| Profit before tax | 35.22 | — | — | 24.85 | +41.7% |
| Net profit for the period | 25.23 | — | — | 18.01 | +40.1% |
| EPS, basic (₹) | 1.98 | — | — | 1.41 | +40.4% |
| Net margin (%) | 19.6 | — | 20.1 |
Standalone
- Filed with BSE
- 06 Feb 2019, 14:31 IST
- Board meeting
- 05 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE